DigiPath & PathXL Create Digital Pathology Education Partnership

Share Article

DigiPath and PathXL have joined together to increase user adoption of digital pathology within North America based academic medical centers through educational applications.

DigiPath, Inc®, a provider of affordable, innovative, and reliable digital pathology solutions, and PathXL Ltd., a company that specializes in developing web-based software for digital pathology, have joined together to increase user adoption of digital pathology within North America based academic medical centers through educational applications.

DigiPath and PathXL will be showcasing PathXL™ Tutor and PathXL™ Simulate digital pathology education applications as the only PREMIER Platinum Industry Sponsors at the Association of Pathology Chairs Annual Meeting in Monterey, CA, USA from July 13 through July 15, 2011.

PathXL™ Tutor allows users to effectively create and manage digital slides and other content, publish online, share and view from anywhere in the world. PathXL™ Tutor provides on-line virtual microscopy teaching, educational, CPD and competency exam resources in minutes, significantly enhancing student, trainee and the professional experience.
PathXL™ Simulate supports early stage training for residents in pathology. Trainees can work through real cases and assess how well they have performed. This approach to training has been completely embraced by numerous laboratories worldwide.
“For over seven years, PathXL has been the European leader in implementing digital pathology medical education software applications,” stated Des Speed, Chief Executive Officer of PathXL. “60% of United Kingdom trained pathologists utilize PathXL™ Tutor each year.”

“PathXL’s innovative product line is the foundation of DigiPath’s digital pathology solution portfolio” said Eric Stoppenhagen, Chief Executive Offer of DigiPath. “DigiPath and PathXL are well positioned to be the market leader within digital pathology medical education.”

About DigiPath, Inc.
DigiPath, Inc. provides the next generation of affordable, innovative, and reliable digital pathology solutions. DigiPath’s advisors bring over 60 years combined expertise in pioneering digital pathology, implementing over 500 installations at community pathology practices, hospitals, academic medical centers, reference laboratories, biopharma organizations, and life science research institutions worldwide.

About PathXL Ltd.
PathXL Ltd is a company that specializes in developing web-based software for Digital Pathology. Their proprietary web-based image management database and digital slide viewing platform – PathXL™ – together with purpose built application software, underpins a wide range of applications including (i) education and training in pathology, (ii) Digital slide archiving, (iii) cloud based digital pathology (iv) biobanking, (v) biomarker discovery and multiplex data management and analysis and (vi) web-based image analysis for tissue analysis.

SAFE HARBOR STATEMENT
This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. DigiPath has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect DigiPath's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause DigiPath's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. DigiPath undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

DigiPath Media Relations
DigiPath, Inc.
702-527-2060
Email >
Visit website